Dual-Responsive Shape-Transformable Charge-Reversible Nanoparticles Combined with Chemo-Photodynamic-Immunotherapy for the Treatment of Breast Cancer and Lung Metastasis
Herein, a dual-responsive shape-transforming charge-reversal integrated nanomedicine system (DHP@BPP) is developed for the co-delivery of the photosensitizer pyro pheophorbide-alpha (Ppa), anti-programmed cell death ligand 1 (PD-L1) peptide (dPPA), and tumor-associated macrophages (TAMs)-regulating drug berberrubine (BBR). Hydrophobic Ppa and hydrophilic BBR are linked by matrix metalloproteinase-2 (MMP-2) responsive peptide (PMGMRKLVFF) to form BPP. BPP can self-assemble into spherical nanoparticles with positive charge, which undergo shape transformation to nanofibers upon cleavage by MMP-2 at tumor sites. The dPPA is conjugated with hexa-histidine and polyethylene glycol to form DHP, which is then electrostatically adsorbed onto the surface of BPP to form DHP@BPP with negative surface charge. The DHP not only enhances the tumor-targeting but also induces DHP disassociation and charge reversal of DHP@BPP due to protonation of histidine at the tumor site, thereby increasing tumor penetration while maintaining long blood circulation. Most importantly, through the combination of chemo-photodynamic-immunotherapy, it can repolarize TAMs from M2-type to M1-type while reducing PD-L1 expression to reshape the immunosuppressive tumor microenvironment, thereby synergistically enhancing the effect of immunogenic cell death. In conclusion, this study offered a simple but effective idea for the treatment of immunosuppressive cancers through the combination of shape transformation and charge reversal, integrating chemo-photodynamic-immunotherapy. This research utilizes the intrinsic properties of various drugs to design a novel pH-responsive charge-reversal, MMP-2-responsive shape-transformable, carrier-free nanoparticles, which are combined with chemo-photodynamic-immunotherapy for the treatment of breast cancer and lung metastasis. This dual-responsive nanomedicine exhibits multiple functionalities while maintaining a simple structure, enhancing tumor penetration, retention, and therapeutic efficacy through the integration of various mechanisms. image
基金:
National Natural Science Foundation of China [82173762]; Key Research and Development Program of the Science and Technology Department of Sichuan Province [2023NSFSC1195]; Fundamental of Research Funds for the Central Universities
第一作者机构:[1]Sichuan Univ, Educ Minist, Sichuan Engn Lab Plant Sourced Drug, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610064, Peoples R China[2]Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Peoples R China
通讯作者:
通讯机构:[1]Sichuan Univ, Educ Minist, Sichuan Engn Lab Plant Sourced Drug, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610064, Peoples R China[2]Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Peoples R China
推荐引用方式(GB/T 7714):
Jia Wenfeng,Gong Bokai,Chen Jiantao,et al.Dual-Responsive Shape-Transformable Charge-Reversible Nanoparticles Combined with Chemo-Photodynamic-Immunotherapy for the Treatment of Breast Cancer and Lung Metastasis[J].ADVANCED FUNCTIONAL MATERIALS.2024,34(48):doi:10.1002/adfm.202408581.
APA:
Jia, Wenfeng,Gong, Bokai,Chen, Jiantao,Yan, Jia,Shi, Yulong...&Gao, Huile.(2024).Dual-Responsive Shape-Transformable Charge-Reversible Nanoparticles Combined with Chemo-Photodynamic-Immunotherapy for the Treatment of Breast Cancer and Lung Metastasis.ADVANCED FUNCTIONAL MATERIALS,34,(48)
MLA:
Jia, Wenfeng,et al."Dual-Responsive Shape-Transformable Charge-Reversible Nanoparticles Combined with Chemo-Photodynamic-Immunotherapy for the Treatment of Breast Cancer and Lung Metastasis".ADVANCED FUNCTIONAL MATERIALS 34..48(2024)